Pfizer Inc. (BCBA:PFE)

Market Cap	199.64T
Revenue (ttm)	75.80T
Net Income (ttm)	12.77T
Shares Out	n/a
EPS (ttm)	2,248.99
PE Ratio	15.64
Forward PE	8.83
Dividend	307.41 (3.45%)
Ex-Dividend Date	Jul 25, 2025

Volume	10,149
Average Volume	20,376
Open	8,760.00
Previous Close	8,910.00
Day's Range	8,685.00 - 8,850.00
52-Week Range	5,990.00 - 9,380.00
Beta	0.46
RSI	70.32
Earnings Date	Oct 28, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1849
• Employees: 81,000
• Stock Exchange: Buenos Aires Stock Exchange
• Ticker Symbol: PFE

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD